Dechert LLP has been shortlisted in four categories in Legal Week’s British Legal Awards 2017, which celebrate achievement, excellence and innovation in the UK’s legal profession.
In the “M&A Team of the Year (Large Deal)” category, a Dechert team led by corporate partner Jonathan Angell was shortlisted for advising oil and gas independent Chrysaor on its acquisition of Shell’s interests in 15 oilfields and several pipelines in the North Sea. The Dechert team brought in EIG Global Energy Partners affiliate Harbour Energy, guided Chrysaor through the competitive auction, advised on the terms of the acquisition and coordinated input from the seven law firms involved, in addition to Shell’s in-house deal teams. As a result of the transaction, Chrysaor will become the UK’s leading independent exploration and production company focused on the North Sea.
In the “Private Equity Team of the Year” category, Dechert was shortlisted for advising buyout investor Mid Europa Partners on its acquisition of Romanian supermarket business Profi Rom Food, the largest deal ever completed by a private equity fund in Romania. Dechert pursued a two-pronged approach to the representation: partner John Markland, co-head of Dechert’s European finance team, focused on the debt financing that Mid Europa would need, while private equity partner Ross Allardice led Mid Europa through preparations for the acquisition itself.
In the “Banking and Finance Team of the Year” category, Dechert was shortlisted for guiding the Arab Republic of Egypt through a number of significant bond issuances. Dechert’s international capital markets group, led by Camille Abousleiman, advised Egypt on the issuance of US$11 billion of bonds in just six months, including the largest Egyptian public bond issuance and the largest bond issuance from the African continent.
In the “Commercial Team of the Year” category, a team led by corporate partners Jonathan Schur and Graham Defries was shortlisted for shepherding British biotech Bicycle Therapeutics through back-to-back collaboration deals covering possible uses of its bicyclic peptide technology. In December 2016, Bicycle Therapeutics signed an agreement with AstraZeneca, worth up to US$1 billion, covering possible treatments for a range of respiratory, cardiovascular and metabolic disorders and reached a second agreement shortly after with Cancer Research UK concerning possible treatments for cancer.
Winners will be announced at a ceremony at Finsbury Square in London on November 30.
About Dechert
Dechert is a global specialist law firm focused on sectors with the greatest complexities and highest regulatory demands. We deliver practical commercial insight and judgment to our clients' most important matters. Nothing stands in the way of giving clients the best of the firm's entrepreneurial energy and seamless collaboration in a way that is distinctively Dechert.
In the “M&A Team of the Year (Large Deal)” category, a Dechert team led by corporate partner Jonathan Angell was shortlisted for advising oil and gas independent Chrysaor on its acquisition of Shell’s interests in 15 oilfields and several pipelines in the North Sea. The Dechert team brought in EIG Global Energy Partners affiliate Harbour Energy, guided Chrysaor through the competitive auction, advised on the terms of the acquisition and coordinated input from the seven law firms involved, in addition to Shell’s in-house deal teams. As a result of the transaction, Chrysaor will become the UK’s leading independent exploration and production company focused on the North Sea.
In the “Private Equity Team of the Year” category, Dechert was shortlisted for advising buyout investor Mid Europa Partners on its acquisition of Romanian supermarket business Profi Rom Food, the largest deal ever completed by a private equity fund in Romania. Dechert pursued a two-pronged approach to the representation: partner John Markland, co-head of Dechert’s European finance team, focused on the debt financing that Mid Europa would need, while private equity partner Ross Allardice led Mid Europa through preparations for the acquisition itself.
In the “Banking and Finance Team of the Year” category, Dechert was shortlisted for guiding the Arab Republic of Egypt through a number of significant bond issuances. Dechert’s international capital markets group, led by Camille Abousleiman, advised Egypt on the issuance of US$11 billion of bonds in just six months, including the largest Egyptian public bond issuance and the largest bond issuance from the African continent.
In the “Commercial Team of the Year” category, a team led by corporate partners Jonathan Schur and Graham Defries was shortlisted for shepherding British biotech Bicycle Therapeutics through back-to-back collaboration deals covering possible uses of its bicyclic peptide technology. In December 2016, Bicycle Therapeutics signed an agreement with AstraZeneca, worth up to US$1 billion, covering possible treatments for a range of respiratory, cardiovascular and metabolic disorders and reached a second agreement shortly after with Cancer Research UK concerning possible treatments for cancer.
Winners will be announced at a ceremony at Finsbury Square in London on November 30.
About Dechert
Dechert is a global specialist law firm focused on sectors with the greatest complexities and highest regulatory demands. We deliver practical commercial insight and judgment to our clients' most important matters. Nothing stands in the way of giving clients the best of the firm's entrepreneurial energy and seamless collaboration in a way that is distinctively Dechert.
Subscribe to Dechert Updates